Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Methods (San Diego, Calif.)|March 9, 2004
A two-step two-hybrid system to identify functionally significant protein-protein interactionsMaxim Poustovoitov, Ilya Serebriiskii, Peter D AdamsMethods in Molecular Biology (Clifton, N.J.)|June 29, 2004
Biochemical analysis of the cell cycle and cell cycle checkpoints in transiently transfected cells after collection with magnetic beadsXiaofen Ye, Maxim Poustovoitov, Hidelita Santos, et al.Cancer Cell|April 23, 2013
A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1Weizhou Zhang, Wei Tan, Xuefeng Wu, et al.Scientific Reports|October 1, 2016
Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's DiseaseIbon Garitaonandia, Rodolfo Gonzalez, Trudy Christiansen-Weber, et al.Journal of Virology|October 31, 2008
Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3Aruna P Ambagala, Trent Bosma, Mir A Ali, et al.Cell Transplantation|April 4, 2015
Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's diseaseRodolfo Gonzalez, Ibon Garitaonandia, Andrew Crain, et al.Proceedings of the National Academy of Sciences of the United States of America|October 20, 2010
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemiaWeizhou Zhang, Arnon P Kater, George F Widhopf, et al.Cell Transplantation|May 24, 2016
Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's DiseaseRodolfo Gonzalez, Ibon Garitaonandia, Maxim Poustovoitov, et al.Pageof 1